Yasa G. Mutlu

Gaziantep, 27470, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience.

Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience.

Journal: Journal of clinical medicine

Published: December 09, 2025

The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History.

The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History.

Journal: Clinical lymphoma, myeloma & leukemia

Published: August 09, 2025

Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients.

Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients.

Journal: American journal of hematology

Published: August 08, 2025

The Contributions of Turkish Hematology to the Global Literature: A Comparative Analysis

The Contributions of Turkish Hematology to the Global Literature: A Comparative Analysis

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: May 12, 2025

Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience.

Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience.

Journal: Transplant immunology

Published: May 01, 2025

When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma.

When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma.

Journal: Annals of hematology

Published: July 19, 2024

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.

Journal: Leukemia research

Published: January 26, 2024

Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients.

Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: December 18, 2023

Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case.

Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case.

Journal: Frontiers in immunology

Published: August 11, 2023

Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?

Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?

Journal: The Eurasian journal of medicine

Published: July 05, 2023

Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 years.

Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 years.

Journal: Cytotherapy

Published: May 31, 2023

Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: May 12, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026